BRADLEY KEEL: Open Payments
NPI 1003041641 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 74 payments from 18 companies in 2025. Trend: 2023 $899 · 2024 $1,347 · 2025 $1,453
Food & beverage: $1,453
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $245 |
| Astellas Pharma US Inc | 8 | $183 |
| Novo Nordisk Inc | 7 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $111 |
| Axsome Therapeutics, Inc. | 4 | $103 |
| ABBVIE INC. | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| PFIZER INC. | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
Products named: MOUNJARO, Veozah, CAPLYTA, Auvelity, REXULTI, VRAYLAR, Ozempic, Rybelsus.
Industry payments across TN — which companies pay providers there.
